Hims & Hers (HIMS) legal chief sells 9,463 shares in planned trade

Rhea-AI Filing Summary

Hims & Hers Health, Inc. Chief Legal Officer Soleil Boughton sold 9,463 shares of Class A Common Stock in an open-market transaction at $30.00 per share. After the sale, Boughton directly holds 299,368 shares. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.

Insider Trade Summary 10b5-1

Net Seller: 9,463 shares ($283,890)

Net Sell 1 txn

Insider Boughton Soleil

Role Chief Legal Officer

Sold 9,463 shs ($284K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	9,463	$30.00	$284K

Holdings After Transaction: Class A Common Stock — 299,368 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 9,463 shares Sale price: $30.00 per share Shares held after sale: 299,368 shares +2 more

5 metrics

Shares sold 9,463 shares Open-market sale of Class A Common Stock

Sale price $30.00 per share Price for the 9,463 shares sold

Shares held after sale 299,368 shares Direct holdings post-transaction

Gross sale value $283,890 9,463 shares sold at $30.00 per share

Transaction date 2026-04-20 Date of open-market sale

Key Terms

Class A Common Stock, open-market sale, Rule 10b5-1 trading plan, Form 4

4 terms

Class A Common Stock financial

"security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Rule 10b5-1 trading plan regulatory

"sales were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"The sales reported on this Form 4 were effected"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boughton Soleil

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/20/2026		S(1)		9,463	D	$30	299,368	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HIMS Chief Legal Officer report?

The Chief Legal Officer of Hims & Hers Health, Inc. (HIMS) reported an open-market sale of 9,463 shares of Class A Common Stock at $30.00 per share. This reduced, but did not eliminate, the executive’s direct equity stake in the company.

How many HIMS shares does the insider hold after this Form 4?

Following the reported transaction, the insider directly holds 299,368 shares of Hims & Hers Health, Inc. Class A Common Stock. This figure comes directly from the Form 4 and shows the remaining ownership position after the open-market sale.

Was the HIMS insider sale made under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were effected under a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, indicating the transactions were arranged in advance rather than timed discretionarily.

What price did the HIMS insider receive for the sold shares?

The insider’s open-market sale of Hims & Hers Health, Inc. stock was executed at $30.00 per share. The Form 4 lists this transaction price for the 9,463 shares sold, providing a clear view of the sale level in the market.

Is this HIMS Form 4 transaction a purchase or a sale?

This Form 4 reports a sale of Class A Common Stock by the Hims & Hers Health, Inc. Chief Legal Officer. The transaction code is “S” and the description identifies it as an open-market sale, not a purchase or option exercise.